Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2010 Nov;126(5):938-44.
doi: 10.1542/peds.2009-3649. Epub 2010 Oct 25.

Variation in methods of predicting adult height for children with idiopathic short stature

Lisa Swartz Topor  1 , Henry A Feldman, Howard Bauchner, Laurie E Cohen
Affiliations
Comparative Study

Variation in methods of predicting adult height for children with idiopathic short stature

Lisa Swartz Topor et al. Pediatrics. 2010 Nov.

Abstract

Objective: Recombinant human growth hormone (GH) is approved for treatment of children with idiopathic short stature, and endocrinologists often depend on algorithms to predict adult height. Because algorithm performance often is included in treatment decisions, we sought to evaluate agreement among height prediction formulas.

Methods: We identified 3 commonly used algorithms for height prediction, the Bayley-Pinneau, Roche-Wainer-Thissen, and Khamis-Roche methods. We constructed simulated samples of children with typical distributions of ages, heights, weights, bone ages, and parental heights seen in patients with idiopathic short stature, and we applied the algorithms to the simulated sample to determine whether predicted adult height was <160 cm for boys or <150 cm for girls (<1.2nd height percentiles for adults).

Results: We found substantial disagreement among algorithms in the proportions of simulated cases with predicted adult heights of <1.2nd percentile, a cutoff value that may influence GH treatment decisions. With the Bayley-Pinneau formula, 43% of boys and 81% of girls had predicted adult heights below this threshold; with the Khamis-Roche method, only 3% of boys and 0.2% of girls had predicted heights of <1.2nd percentile. Roche-Wainer-Thissen predictions were between those values. Overall agreement of the methods was poor (κ = 0.21) for boys and negative for girls.

Conclusions: Wide variation exists among formulas used to predict adult heights. Because these algorithms may be used in decisions regarding whether to initiate GH treatment and assessment of the efficacy of GH in research trials, it is important for parents, pediatricians, and investigators to recognize the considerable variation involved in height predictions.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Distributions of adult heights predicted by using 3 height prediction algorithms. Bars to the left of the red line represent predicted adult heights that are below the 1.2nd percentile for adult height (160 cm or 63 inches for men and 150 cm or 59 inches for women). The blue and pink bars (at extreme right) represent simulated samples that did not allow for height prediction with the BP algorithm because bone age was less than the value required for the algorithm.
See this image and copyright information in PMC

References

    1. (FDA) FaDA. [Accessed 10/31/2005];FDA Talk Paper: FDA Approves Humatrope for Short Stature. http://www.fda.gov/bbs/topics/ANSWERS/2003/ANS01242.html. Published 2003.
    1. Cuttler L, Silvers JB. Growth hormone treatment for idiopathic short stature: implications for practice and policy. Arch Pediatr Adolesc Med. 2004;158(2):108–110. - PubMed
    1. Leschek EW, Rose SR, Yanovski JA, Troendle JF, Quigley CA, Chipman JJ, et al. Effect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab. 2004;89(7):3140–3148. - PubMed
    1. Wit JM, Rekers-Mombarg LT, Cutler GB, Crowe B, Beck TJ, Roberts K, et al. Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effect. J Pediatr. 2005;146(1):45–53. - PubMed
    1. Bryant J, Baxter L, Cave CB, Milne R. Recombinant growth hormone for idiopathic short stature in children and adolescents. Cochrane Database Syst Rev. 2007;(3):CD004440. - PubMed

Publication types